- Home
- GPCR vs IBTA Comparison
GPCR vs IBTA Comparison
Compare GPCR & IBTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- IBTA
- Stock Information
- Founded
- GPCR 2016
- IBTA 2011
- Country
- GPCR United States
- IBTA United States
- Employees
- GPCR N/A
- IBTA N/A
- Industry
- GPCR
- IBTA
- Sector
- GPCR
- IBTA
- Exchange
- GPCR Nasdaq
- IBTA Nasdaq
- Market Cap
- GPCR 1.1B
- IBTA 892.4M
- IPO Year
- GPCR 2023
- IBTA 2024
- Fundamental
- Price
- GPCR $20.91
- IBTA $26.61
- Analyst Decision
- GPCR Strong Buy
- IBTA Hold
- Analyst Count
- GPCR 9
- IBTA 10
- Target Price
- GPCR $75.63
- IBTA $44.33
- AVG Volume (30 Days)
- GPCR 1.1M
- IBTA 641.5K
- Earning Date
- GPCR 11-12-2025
- IBTA 11-12-2025
- Dividend Yield
- GPCR N/A
- IBTA N/A
- EPS Growth
- GPCR N/A
- IBTA 2512.20
- EPS
- GPCR N/A
- IBTA 2.84
- Revenue
- GPCR N/A
- IBTA $367,604,000.00
- Revenue This Year
- GPCR N/A
- IBTA N/A
- Revenue Next Year
- GPCR N/A
- IBTA $7.41
- P/E Ratio
- GPCR N/A
- IBTA $9.38
- Revenue Growth
- GPCR N/A
- IBTA 3.49
- 52 Week Low
- GPCR $13.22
- IBTA $22.50
- 52 Week High
- GPCR $45.37
- IBTA $79.80
- Technical
- Relative Strength Index (RSI)
- GPCR 58.61
- IBTA 42.04
- Support Level
- GPCR $18.49
- IBTA $25.59
- Resistance Level
- GPCR $22.25
- IBTA $27.51
- Average True Range (ATR)
- GPCR 1.16
- IBTA 1.20
- MACD
- GPCR 0.15
- IBTA 0.46
- Stochastic Oscillator
- GPCR 66.38
- IBTA 41.60
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About IBTA Ibotta Inc. Class A Common Stock
Ibotta Inc is a performance marketing platform. It allows CPG brands to deliver digital promotions to consumers through a single, convenient network called the Ibotta Performance Network (IPN).